Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-cohort, Exploratory Clinical Study of Pyrrotinib Maleate in HER2-positive Early Breast Cancer

NCT06718335 is registered in ClinicalTrials.gov with Nie Jianyun as lead sponsor.

NCT NCT06718335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06718335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-cohort, Exploratory Clinical Study of Pyrrotinib Maleate in HER2-positive Early Breast Cancer
Lead sponsor
Nie Jianyun
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 30, 2024
Completion date
December 30, 2029
Enrollment
156 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer